DE eng

Search in the Catalogues and Directories

Page: 1 2
Hits 1 – 20 of 37

1
Facilitators and barriers of women's participation in HIV clinical research in Switzerland: A qualitative study.
In: HIV medicine, vol. 23, no. 4, pp. 441-447 (2022)
BASE
Show details
2
A Therapeutic Relational Agent for Reducing Problematic Substance Use (Woebot): Development and Usability Study.
In: Journal of medical Internet research, vol 23, iss 3 (2021)
BASE
Show details
3
New Directions in Treatments Targeting Stroke Recovery.
In: Stroke, vol 49, iss 12 (2018)
BASE
Show details
4
Cognitive Working Memory Training (CWMT) in adolescents suffering from Attention-Deficit/Hyperactivity Disorder (ADHD): A controlled trial taking into account concomitant medication effects.
In: Psychiatry research, vol. 269, pp. 79-85 (2018)
BASE
Show details
5
Refractory depression: mechanisms and evaluation of radically open dialectical behaviour therapy (RO-DBT) [REFRAMED]: protocol for randomised trial.
Lynch, TR; Whalley, B; Hempel, RJ. - : BMJ Publishing Group, 2015
BASE
Show details
6
Painful oral aphthous-like lesions in patient with kidney cancer after target therapy and bisphosphonate administration: a case report of adverse drug reaction.
Mauceri, R; Di Fede, O; Perrone,D. - : Edizioni Minerva Medica, 2015. : country:IT, 2015
BASE
Show details
7
Refractory depression: mechanisms and evaluation of radically open dialectical behaviour therapy (RO-DBT) [REFRAMED]: protocol for randomised trial.
Lynch, TR; Whalley, B; Hempel, RJ. - : England, 2015
BASE
Show details
8
Atomoxetine improved attention in children and adolescents with attention-deficit/hyperactivity disorder and dyslexia in a 16 week, acute, randomized, double-blind trial
In: PMC (2013)
BASE
Show details
9
Innovative solutions to novel drug development in mental health.
In: Symplectic Elements at Oxford ; Europe PubMed Central ; PubMed (http://www.ncbi.nlm.nih.gov/pubmed/) ; Web of Science (Lite) (http://apps.webofknowledge.com/summary.do) ; Scopus (http://www.scopus.com/home.url) ; CrossRef (2013)
BASE
Show details
10
Innovative solutions to novel drug development in mental health.
In: Neurosci Biobehav Rev , 37 (10 Pt 1) pp. 2438-2444. (2013) (2013)
BASE
Show details
11
An evaluation of the parents under pressure programme: a study protocol for an RCT into its clinical and cost effectiveness
Barlow, Jane; Sembi, Sukhdev; Gardner, Frances. - : BioMed Central, 2013
BASE
Show details
12
Research Article ASSESSMENT OF COLLEGE STUDENT’S AWARENESS ABOUT TUBERCULOSIS IN AHMEDNAGAR
In: http://www.ijrdpl.com/docs/5th/6 Res.pdf (2012)
BASE
Show details
13
Association between ambulatory 24-hour blood pressure levels and brain volume reduction: a cross-sectional elderly population-based study
In: ISSN: 1524-4563 ; Hypertension (Dallas, Tex. : 1979) ; https://hal.univ-angers.fr/hal-03355591 ; Hypertension (Dallas, Tex. : 1979), 2012, 60 (5), pp.1324-31. ⟨10.1161/hypertensionaha.112.193409⟩ (2012)
Abstract: International audience ; Previous literature has shown mixed results regarding the association between blood pressure levels and brain volume reduction. The objectives of this study were to determine whether high blood pressure levels were associated with focal brain volume reduction and whether high blood pressure-related focal brain volume reduction was associated with a decline in executive function performance. On the basis of a cross-sectional design, 24-hour ambulatory blood pressure measurements, as well as brain morphology from 3-dimensional magnetic resonance images, were assessed among 183 participants (mean, 65 +/- 0.6 years; 62.4% women). Average levels of systolic and diastolic blood pressures, as well as dip, pulse pressure, and mean arterial blood pressure, were used as outcomes. Cortical gray and white matter volumes were determined by automatic calculation using Statistical Parametric Mapping segmentation. Folstein's Mini-Mental State Examination, digit span, part B of Trail Making, and Stroop tests were used to assess executive function performance. Sex, use of antihypertensive drugs, duration of hypertension, leukoaraiosis, body mass index, education level, and total brain matter volume were used as potential confounders. A significant blood pressure-related decrease in gray matter volume of the left supplementary motor areas (Brodmann area 6) and of the left superior and middle frontal gyrus (Brodmann area 8) was shown. No significant decrease was found with white matter volume. Blood pressure-related decreases in gray matter volume were significantly associated with a decline in executive function performance. The association of high blood pressure with brain volume reduction may in part explain blood pressure-related cognitive decline leading to dementia.
Keyword: [SHS]Humanities and Social Sciences; Aged; Ambulatory/ methods; Antihypertensive Agents/therapeutic use; Blood Pressure Monitoring; Blood Pressure/drug effects/ physiology; Brain Mapping; Brain/ pathology/physiopathology; Cognition/physiology; Cross-Sectional Studies; Female; Humans; Hypertension/drug therapy/physiopathology; Linear Models; Magnetic Resonance Imaging/ methods; Male; Middle Aged; Multivariate Analysis; Population Surveillance/methods; Psychomotor Performance/physiology; Time Factors
URL: https://doi.org/10.1161/hypertensionaha.112.193409
https://hal.univ-angers.fr/hal-03355591
BASE
Hide details
14
Basal insulin and cardiovascular and other outcomes in dysglycemia.
In: New England Journal of Medicine, vol. 367, no. 4, pp. 319-328 (2012)
BASE
Show details
15
n-3 fatty acids and cardiovascular outcomes in patients with dysglycemia.
In: New England Journal of Medicine, vol. 367, no. 4, pp. 309-318 (2012)
BASE
Show details
16
Cardiorenal end points in a trial of aliskiren for type 2 diabetes.
In: New England Journal of Medicine, vol. 367, no. 23, pp. 2204-2213 (2012)
BASE
Show details
17
Crossover trial of subacute computerized aphasia therapy for anomia with the addition of either levodopa or placebo
In: ISSN: 1545-9683 ; Neurorehabilitation and Neural Repair, Vol. 25, No 1 (2011) pp. 43-47 (2011)
BASE
Show details
18
Once-yearly zoledronic acid and days of disability, bed rest, and back pain: randomized, controlled HORIZON Pivotal Fracture Trial.
In: Journal of Bone and Mineral Research, vol. 26, no. 5, pp. 984-992 (2011)
BASE
Show details
19
Nova Scotia Medical Bulletin 5(4), 1926
Medical Society of Nova Scotia. - : Halifax, Medical Society of Nova Scotia, 2010
BASE
Show details
20
Effect of once-yearly zoledronic acid on the spine and hip as measured by quantitative computed tomography: results of the HORIZON Pivotal Fracture Trial.
In: Osteoporosis International, vol. 21, no. 7, pp. 1277-1285 (2010)
BASE
Show details

Page: 1 2

Catalogues
0
0
0
0
0
0
0
Bibliographies
0
0
0
0
0
0
0
0
0
Linked Open Data catalogues
0
Online resources
0
0
0
0
Open access documents
37
0
0
0
0
© 2013 - 2024 Lin|gu|is|tik | Imprint | Privacy Policy | Datenschutzeinstellungen ändern